Embecta Corp Share Price: EMBC (Embecta Corp) Stock Price Today & Updates | INDmoney

Question 1

What is Embecta Corp share price today?

Accepted Answer

Embecta Corp (EMBC) share price today is {{live_price}}.

Question 2

Can Indians buy Embecta Corp shares?

Accepted Answer

Yes, Indians can invest in the Embecta Corp (EMBC) from India.

With INDmoney, you can buy Embecta Corp at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Embecta Corp at zero transaction cost.

Question 3

How can I buy Embecta Corp shares from India?

Accepted Answer

It is very easy to buy Embecta Corp from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Embecta Corp be purchased?

Accepted Answer

Yes, you can buy fractional shares of Embecta Corp with INDmoney app.

Question 5

What are the documents required to start investing in Embecta Corp stocks?

Accepted Answer

To start investing in Embecta Corp, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Embecta Corp

Accepted Answer

Today’s highest price of Embecta Corp (EMBC) is {{1_rba_end}}.

Today’s lowest price of Embecta Corp (EMBC) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Embecta Corp

Accepted Answer

Today's market capitalisation of Embecta Corp EMBC is 942.9M

Question 8

What is the 52 Week High and Low Range of Embecta Corp

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Embecta Corp is down from its 52 Week High?

Accepted Answer

Embecta Corp (EMBC) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Embecta Corp is up from its 52 Week low?

Accepted Answer

Embecta Corp (EMBC) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Embecta Corp?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Embecta Corp

Accepted Answer

Mr. Devdatt  Kurdikar is the current Chief Executive Officer (CEO) of Embecta Corp.

Period	Embecta Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	53.93%	6.5%	0.0%
6 Months	-8.27%	7.1%	0.0%
1 Year	-25.46%	9.8%	0.0%
3 Years	-47.06%	14.2%	-20.2%

Market Capitalization	942.9M
Book Value	- $13.35
Dividend Share	0.6
Dividend Yield	3.67%
Earnings Per Share (EPS)	1.22
PE Ratio	13.4
Wall Street Target Price	15.73

Profit Margin	6.2%
Operating Margin TTM	25.0%

Return On Assets TTM	9.74%
Return On Equity TTM	0.0%

Revenue TTM	1.1B
Revenue Per Share TTM	19.72
Quarterly Revenue Growth YOY	3.5999999999999996%
Gross Profit TTM	774.9M
EBITDA	223.0M
Diluted Eps TTM	1.22
Quarterly Earnings Growth YOY	1.08

Embecta Corp (EMBC)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Increasing Revenue

Increasing Net Profit

Vs ISRG

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	2.28
EPS Estimate Next Year	2.2
EPS Estimate Current Quarter	0.4
EPS Estimate Next Quarter	0.55

	FY20	Y/Y Change
Revenue	1.1B	↓ 2.12%
Net Income	427.6M	↓ 1.02%
Net Profit Margin	39.39%	↑ 0.44%

	FY21	Y/Y Change
Revenue	1.2B	↑ 7.32%
Net Income	414.8M	↓ 2.99%
Net Profit Margin	35.61%	↓ 3.78%

	FY22	Y/Y Change
Revenue	1.1B	↓ 3.05%
Net Income	223.6M	↓ 46.09%
Net Profit Margin	19.8%	↓ 15.81%

	FY23	Y/Y Change
Revenue	1.1B	↓ 0.77%
Net Income	70.4M	↓ 68.52%
Net Profit Margin	6.28%	↓ 13.52%

	Q4 FY22	Q/Q Change
Revenue	275.7M	↑ 0.4%
Net Income	35.2M	↓ 304.65%
Net Profit Margin	12.77%	↑ 19.03%

	Q1 FY23	Q/Q Change
Revenue	277.1M	↑ 0.51%
Net Income	14.0M	↓ 60.23%
Net Profit Margin	5.05%	↓ 7.72%

	Q2 FY23	Q/Q Change
Revenue	286.1M	↑ 3.25%
Net Income	15.2M	↑ 8.57%
Net Profit Margin	5.31%	↑ 0.26%

	Q3 FY23	Q/Q Change
Revenue	281.9M	↓ 1.47%
Net Income	6.0M	↓ 60.53%
Net Profit Margin	2.13%	↓ 3.18%

	Q4 FY23	Q/Q Change
Revenue	277.3M	↓ 1.63%
Net Income	20.1M	↑ 235.0%
Net Profit Margin	7.25%	↑ 5.12%

	FY19	Y/Y Change
Total Assets	745.0M	-
Total Liabilities	126.0M	-

	FY20	Y/Y Change
Total Assets	738.0M	↓ 0.94%
Total Liabilities	166.0M	↑ 31.75%

	FY21	Y/Y Change
Total Assets	788.0M	↑ 6.78%
Total Liabilities	194.0M	↑ 16.87%

	Q2 FY23	Q/Q Change
Total Assets	1.3B	↑ 3.48%
Total Liabilities	2.1B	↑ 1.42%

	Q1 FY24	Q/Q Change
Revenue	287.2M	↑ 3.57%
Net Income	28.9M	↑ 43.78%
Net Profit Margin	10.06%	↑ 2.81%

	FY19	Y/Y Change
Operating Cash Flow	505.0M	-
Investing Cash Flow	-69.0M	-
Financing Cash Flow	-436.0M	-

	FY20	Y/Y Change
Operating Cash Flow	498.5M	↓ 1.29%
Investing Cash Flow	-42.0M	↓ 39.13%
Financing Cash Flow	-456.6M	↑ 4.72%

	FY21	Y/Y Change
Operating Cash Flow	456.0M	↓ 8.53%
Investing Cash Flow	-39.0M	↓ 7.14%
Financing Cash Flow	-417.0M	↓ 8.67%

	FY22	Y/Y Change
Operating Cash Flow	412.2M	↓ 9.61%
Investing Cash Flow	-24.0M	↓ 38.46%
Financing Cash Flow	-48.0M	↓ 88.49%

	Q4 FY22	Q/Q Change
Operating Cash Flow	60.4M	↑ 4.14%
Investing Cash Flow	-4.7M	↓ 45.35%
Financing Cash Flow	-6.1M	↓ 14.08%

	Q1 FY23	Q/Q Change
Operating Cash Flow	-13.0M	↓ 121.52%
Investing Cash Flow	-5.8M	↑ 23.4%
Financing Cash Flow	-20.7M	↑ 239.34%

	Q2 FY23	Q/Q Change
Operating Cash Flow	-9.3M	↓ 28.46%
Investing Cash Flow	-6.8M	↑ 17.24%
Financing Cash Flow	-12.2M	↓ 41.06%

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Embecta Corp	29.34%	-8.27%	-25.46%	-47.06%	-47.06%
Intuitive Surgical, Inc.	-1.32%	16.54%	32.6%	35.62%	148.32%
Resmed Inc.	11.69%	9.57%	-6.0%	-19.79%	64.22%
Becton, Dickinson And Company	0.5%	-1.64%	-17.69%	-6.68%	-8.49%
West Pharmaceutical Services Inc	-14.37%	-23.3%	-26.95%	-26.58%	102.44%
Alcon Ag	2.41%	20.84%	8.21%	30.7%	54.72%

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Embecta Corp	Sell	$942.9M	-47.06%	13.4	6.2%
Intuitive Surgical, Inc.	Buy	$161.3B	148.32%	78.14	27.65%
Resmed Inc.	Buy	$30.8B	64.22%	32.24	20.91%
Becton, Dickinson And Company	Buy	$68.6B	-8.49%	50.71	6.76%
West Pharmaceutical Services Inc	Buy	$23.7B	102.44%	42.71	19.42%
Alcon Ag	Buy	$45.8B	54.72%	44.05	10.96%

Organization	Embecta Corp
Employees	2200
CEO	Mr. Devdatt Kurdikar
Industry	Healthcare